Oxford BioDynamics says study proves EpiSwitch utility

By

Sharecast News | 13 Oct, 2017

Updated : 15:14

09:30 29/04/24

  • 8.10
  • 0.00%0.00
  • Max: 8.78
  • Min: 8.10
  • Volume: 80,579
  • MM 200 : 0.00

Biotechnology company Oxford BioDynamics announced on Friday that it has presented a poster at the Diabetes Asia 2017 conference in Kuala Lumpur.

Last news

Getir gets out as it exits UK, Europe and US markets
Director dealings: Marshalls CEO makes share purchase
FTSE 100 movers: Frasers rallies on buyback; JD Sports hit by downgrade
Berenberg raises target price on NatWest
US open: Dow builds on Friday's gains